| Product Code: ETC6744139 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Glucocorticoid Agonist Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Glucocorticoid Agonist Market Revenues & Volume, 2021 & 2031F |
3.3 China Glucocorticoid Agonist Market - Industry Life Cycle |
3.4 China Glucocorticoid Agonist Market - Porter's Five Forces |
3.5 China Glucocorticoid Agonist Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 China Glucocorticoid Agonist Market Revenues & Volume Share, By Products, 2021 & 2031F |
3.7 China Glucocorticoid Agonist Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 China Glucocorticoid Agonist Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 China Glucocorticoid Agonist Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Glucocorticoid Agonist Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of autoimmune diseases and chronic inflammatory conditions in China |
4.2.2 Growing awareness and acceptance of glucocorticoid agonists as an effective treatment option |
4.2.3 Rise in healthcare expenditure and investments in healthcare infrastructure in China |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval and market entry |
4.3.2 Concerns regarding the side effects and long-term use of glucocorticoid agonists |
4.3.3 Competition from alternative treatment options such as non-steroidal anti-inflammatory drugs (NSAIDs) |
5 China Glucocorticoid Agonist Market Trends |
6 China Glucocorticoid Agonist Market, By Types |
6.1 China Glucocorticoid Agonist Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 China Glucocorticoid Agonist Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 China Glucocorticoid Agonist Market Revenues & Volume, By Anti-inflammatory, 2021- 2031F |
6.1.4 China Glucocorticoid Agonist Market Revenues & Volume, By Eyes Disorders, 2021- 2031F |
6.1.5 China Glucocorticoid Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China Glucocorticoid Agonist Market, By Products |
6.2.1 Overview and Analysis |
6.2.2 China Glucocorticoid Agonist Market Revenues & Volume, By Corticosterone, 2021- 2031F |
6.2.3 China Glucocorticoid Agonist Market Revenues & Volume, By Fluticasone Propionate, 2021- 2031F |
6.2.4 China Glucocorticoid Agonist Market Revenues & Volume, By Methylprednisolone, 2021- 2031F |
6.2.5 China Glucocorticoid Agonist Market Revenues & Volume, By Mometasone Furoate, 2021- 2031F |
6.2.6 China Glucocorticoid Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China Glucocorticoid Agonist Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 China Glucocorticoid Agonist Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 China Glucocorticoid Agonist Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 China Glucocorticoid Agonist Market Revenues & Volume, By Topical, 2021- 2031F |
6.3.5 China Glucocorticoid Agonist Market Revenues & Volume, By Ocular, 2021- 2031F |
6.3.6 China Glucocorticoid Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.4 China Glucocorticoid Agonist Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 China Glucocorticoid Agonist Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 China Glucocorticoid Agonist Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 China Glucocorticoid Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.5 China Glucocorticoid Agonist Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 China Glucocorticoid Agonist Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 China Glucocorticoid Agonist Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 China Glucocorticoid Agonist Market Revenues & Volume, By Others, 2021- 2031F |
7 China Glucocorticoid Agonist Market Import-Export Trade Statistics |
7.1 China Glucocorticoid Agonist Market Export to Major Countries |
7.2 China Glucocorticoid Agonist Market Imports from Major Countries |
8 China Glucocorticoid Agonist Market Key Performance Indicators |
8.1 Patient adherence rate to prescribed glucocorticoid agonist treatment regimens |
8.2 Number of new product developments and innovations in the glucocorticoid agonist market |
8.3 Rate of adoption of glucocorticoid agonists in different therapeutic areas |
8.4 Average time taken for regulatory approval of new glucocorticoid agonist products |
9 China Glucocorticoid Agonist Market - Opportunity Assessment |
9.1 China Glucocorticoid Agonist Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 China Glucocorticoid Agonist Market Opportunity Assessment, By Products, 2021 & 2031F |
9.3 China Glucocorticoid Agonist Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 China Glucocorticoid Agonist Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 China Glucocorticoid Agonist Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Glucocorticoid Agonist Market - Competitive Landscape |
10.1 China Glucocorticoid Agonist Market Revenue Share, By Companies, 2024 |
10.2 China Glucocorticoid Agonist Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here